Notwithstanding various setbacks, several MDM2 inhibitors have now progressed into late-phase medical development. New strategies have also been formulated to boost the efficacy of MDM2 inhibitors and to mitigate their on-concentrate on toxicity. With this overview, we summarize the progress and worries in the development of the MDM2 focused therapy. https://josephh207ydi0.blogtov.com/profile